SITC Immunotherapy for the Treatment of Renal Cell Carcinoma 2026 Guideline – Key Recommendations

from Clinical Guideline InSights · host Guideline Central

The 2026 Immunotherapy for the Treatment of Renal Cell Carcinoma guideline, highlighting recommendations on diagnostic tests, immunotherapy, patient education, and more. Immunotherapy for the Treatment of Renal Cell CarcinomaSociety for Immunotherapy of CancerMarch 23, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/12674/Full-Text: https://jitc.bmj.com/content/14/3/e013788

Episode metadata supplied by the publisher feed · Published Apr 17, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

SITC Immunotherapy for the Treatment of Renal Cell Carcinoma 2026 Guideline – Key Recommendations

0:00 7:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Guideline InSights?

This episode is 7 minutes long.

When was this Clinical Guideline InSights episode published?

This episode was published on April 17, 2026.

Can I download this Clinical Guideline InSights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!